|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.3000 - 1.3950|
|52 Week Range||0.2368 - 2.6500|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
SEATTLE, March 01, 2018-- CFN Media Group, the leading agency and financial media network dedicated to the North American cannabis industry, today announced that THC BioMed International Ltd. has engaged ...
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2018) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHC), Canada's largest supplier of legal Cannabis Genetics, has entered into a Letter of Intent to purchase a Farm and Greenhouses in the Niagara region of Ontario, Canada. Southern Ontario is home to over 94%, or 12.1 million, of Ontario's total population of 12.9 million people, and about 35% of Canada's total population.InvestmentPitch.com has produced a "video" which ...
Vancouver, British Columbia--(Newsfile Corp. - December 21, 2017) - THC BioMed's (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) subsidiary, THC2GO Dispensers, has officially submitted its application to operate cannabis retail stores in the province of Manitoba. Kelowna, British Columbia based THC also announced that Health Canada has amended the company's ACMPR license to include 4 additional Grow Rooms, which will allow the company to ramp up production, substantially adding an additional 400 kilograms per ...
VANCOUVER, Nov. 20, 2017 /PRNewswire/ - THC BioMed Intl Ltd. (CSE:THC), ("THC" or the "Company") announces the creation of THC2GO Dispensaries. THC, through its wholly-owned subsidiary "THC2GO Dispensaries", has begun the application process to become a cannabis retailer in Manitoba. THC2GO Dispensaries also intends to apply for retail outlets in each Canadian province that permits private cannabis retail outlets.
THC Announces THC2GO DISPENSARIES and Closes Ninth Tranche Private Placement with Alumina
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) is now authorized by Health Canada to sell dried marijuana to patients registered under the Access to Cannabis for Medical Purposes Regulations. The company was previous authorized to sell starting materials to eligible customers. This is a very important milestone for THC, as it allows the company to compete directly with its peers.InvestmentPitch.com has produced a ...
VANCOUVER, Aug. 24, 2017 /PRNewswire/ - THC BioMed Intl Ltd ("THC" or the "Company") (CSE:THC) announces that it is now authorized by Health Canada to sell dried marihuana to registered patients under the ACMPR. While we understand that investors want an upward curve, this must be achieved through genuine fundamentals and not hype.
Vancouver, British Columbia--(Newsfile Corp. - August 15, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) has received a financing commitment of up to $12 million from Alumina Partners LLC. Alumina Partners LLC, a New York-based private equity firm, will be providing, through its Alumina Partners (Ontario) Ltd subsidiary, an equity facility of up to $12 million.InvestmentPitch.com has produced a "video" which discusses this news. If this link is not enabled, ...
VANCOUVER, Aug. 11, 2017 /PRNewswire/ - THC BioMed Intl Ltd ("THC" or the "Company") (CSE:THC) is pleased to announce that following a commitment with Alumina Partners (Ontario) Ltd. ("Alumina") for up to $12,000,000 (twelve million dollars), the Company has issued 483,870 units to Alumina (the "Units") at a price of $0.31 per Unit for gross proceeds of $150,000 (the "Private Placement") as part of the draw down facility. Each Unit consists of one common share ("Private Placement Share") and one common share purchase warrant ("Warrant"). Each whole Warrant entitles Alumina to purchase one common share of the Company for a period of 36 months from closing at a price of $0.3875 per common share.
Categories: Yahoo FinanceGet free summary analysis THC BioMed International Ltd. reports financial results for the quarter ended April 30, 2017. Highlights Summary numbers: Revenues of USD 0.03 million, Net Earnings of USD -0.56 million. Change in operating cash flow of -859.97% compared to same period last year is about the same as change in earnings, likely no ... Read more (Read more...)
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) has received its first order to export dried marijuana to Germany. The company, an authorized licensed producer of dried Marijuana for Medical Purposes with a production only license for fresh marijuana and cannabis oil, is moving forward to meet the regulatory requirements to export to the European Union.InvestmentPitch.com has produced a "video" which discusses this news. If ...
VANCOUVER, June 23, 2017 /PRNewswire/ - THC Biomed Intl Ltd. ("THC") is pleased to announce that it has received an order to export Dried Marihuana to Germany. THC is excited to begin to claw into, what is anticipated to be more than a billion-dollar International Cannabis Market. THC currently offers 29 different Genetic strains for sale and has the largest variety of Genetic strains available in Canada to home growers.
THC Receives Dried Marihuana order from Germany, Appoints New Director, Settles Debt for Shares
VANCOUVER, May 8, 2017 /PRNewswire/ - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE:THC) announces that it has purchased Clone Shipper LLC for USD $1,000,000. The Issuer will now add the Clone Shipper Business to its existing operations. Clone Shipper is a U.S. based company, specializing in packaging products for the transportation of live plants. "The Global demand for securely shipping live plants is increasing with the legalization of Medical Cannabis.